CVS Health Corporation logo

CVS Health Corporation (CVS)

Market Closed
10 Aug, 20:00
NYSE NYSE
$
95. 67
-0.03
-0.0313%
$
126.47B Market Cap
11.4 P/E Ratio
0.64% Div Yield
5.66M Volume
7.87 Eps
$ 95.7
Previous Close
Add Transaction
Day Range
94.68 96.34
Year Range
64.32 110.68
Want to track CVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?

Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Zacks | 1 week ago
Stay Ahead of the Game With CVS Health (CVS) Q2 Earnings: Wall Street's Insights on Key Metrics

Stay Ahead of the Game With CVS Health (CVS) Q2 Earnings: Wall Street's Insights on Key Metrics

Beyond analysts' top-and-bottom-line estimates for CVS Health (CVS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.

Zacks | 1 week ago
CVS Health (CVS) Earnings Expected to Grow: Should You Buy?

CVS Health (CVS) Earnings Expected to Grow: Should You Buy?

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 week ago
CVS Health (CVS) Laps the Stock Market: Here's Why

CVS Health (CVS) Laps the Stock Market: Here's Why

CVS Health (CVS) closed the most recent trading day at $109.34, moving +2.12% from the previous trading session.

Zacks | 1 week ago
4 Medical Stocks With the Right Setup for Q2 Earnings Beats

4 Medical Stocks With the Right Setup for Q2 Earnings Beats

CVS, CAH, HUM and ACAD look ready for Q2 2026 earnings beats as growing demand for medical products and services continues to support performance.

Zacks | 2 weeks ago
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term

Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 weeks ago
How Safe Is CVS Health's Dividend?

How Safe Is CVS Health's Dividend?

CVS Health (NYSE:CVS | CVS Price Prediction) shares closed at $106.89 on July 23, 2026, up 78.2% over the past year.

247wallst | 2 weeks ago
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 2 weeks ago
2 Absurdly Cheap Healthcare Stocks to Buy Before July Ends

2 Absurdly Cheap Healthcare Stocks to Buy Before July Ends

Healthcare is quietly becoming the value hunter's playground of 2026. While the mega cap tech trade keeps sucking up oxygen, two of the largest healthcare names in the S&P 500 are trading at forward multiples that look mispriced against their earnings power.

247wallst | 2 weeks ago
CVS Health (CVS) Surpasses Market Returns: Some Facts Worth Knowing

CVS Health (CVS) Surpasses Market Returns: Some Facts Worth Knowing

The latest trading day saw CVS Health (CVS) settling at $110.6, representing a +2.78% change from its previous close.

Zacks | 2 weeks ago
CVS is now filling prescriptions for dogs and cats. Here's what pet owners need to know

CVS is now filling prescriptions for dogs and cats. Here's what pet owners need to know

Next time you need to fill your pet's prescription, you might be able to pick up your own at the same time. Tuesday CVS Health announced plans to carry dog and cat medications alongside human ones in its pharmacies.

Fastcompany | 2 weeks ago
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?

Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Zacks | 3 weeks ago
Loading...
Load More